TrialFrontiers of medicine2025

Albumin-bound paclitaxel plus anlotinib in patients with recurrent, platinum-resistant primary epithelial ovarian cancer (A-Plus): a phase II, single-arm, prospective study.

Yun Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.